Volume 169, Issue 2

Search all Psychopharmacology articles

September 2003

13 articles in this issue

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data
Gianluigi Tanda
Steven R. Goldberg
Review 24 June 2003 Pages: 115 - 134
Self-administration of Δ⁹-tetrahydrocannabinol (THC) by drug naive squirrel monkeys
Zuzana Justinova
Gianluigi Tanda
Steven R. Goldberg
Original Investigation 24 June 2003 Pages: 135 - 140
Adolescent-onset nicotine self-administration modeled in female rats
Edward D. Levin
Amir H. Rezvani
H. Scott Swartzwelder
Original Investigation 23 May 2003 Pages: 141 - 149
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential
John N. Bain
Mark A. Prendergast
Jerry J. Buccafusco
Original Investigation 27 May 2003 Pages: 150 - 160
Locomotor and discriminative-stimulus effects of cocaine in dopamine D₅ receptor knockout mice
Elizabeth E. Elliot
David R. Sibley
Jonathan L. Katz
Original Investigation 27 May 2003 Pages: 161 - 168
Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats
Leslie Matuszewich
Bryan K. Yamamoto
Original Investigation 27 May 2003 Pages: 169 - 175
On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization
Louk J. M. J. Vanderschuren
Patricia Beemster
Anton N. M. Schoffelmeer
Original Investigation 27 May 2003 Pages: 176 - 185
Hypericum perforatum attenuates nicotine withdrawal signs in mice
Maria A. Catania
Fabio Firenzuoli
Gioacchino Calapai
Original Investigation 29 April 2003 Pages: 186 - 189
Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice
Christopher L. Kliethermes
Deborah A. Finn
John C. Crabbe
Original Investigation 29 May 2003 Pages: 190 - 197
Expectations and placebo responses to caffeine-associated stimuli
Magne Arve Flaten
Ole Aasli
Terry D. Blumenthal
Original Investigation 21 May 2003 Pages: 198 - 204
Varying and "atypical" indications for atypical antipsychotics
Corrado Barbui
Michele Tansella
Silvio Garattini
Letter to the Editors 22 May 2003 Pages: 205 - 206
Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use
W. Wolfgang Fleischhacker
the European Group for Research in Schizophrenia
Letter to the Editors 22 May 2003 Pages: 207 - 210
Lorazepam should no longer be used as a prototypical benzodiazepine
S. Pompéia
O. F. A. Bueno
S. Tufik
Letter to the Editors 28 May 2003 Pages: 211 - 212

Volume 169, Issue 2

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data

Self-administration of Δ⁹-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

Adolescent-onset nicotine self-administration modeled in female rats

Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential

Locomotor and discriminative-stimulus effects of cocaine in dopamine D₅ receptor knockout mice

Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats

On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization

Hypericum perforatum attenuates nicotine withdrawal signs in mice

Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice

Expectations and placebo responses to caffeine-associated stimuli

Varying and "atypical" indications for atypical antipsychotics

Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

Lorazepam should no longer be used as a prototypical benzodiazepine

Navigation